A series of substituted 3H-imidazo[4,5-c]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders neurological and neurodegenerative disorders pain and nociceptive disorders cardiovascular disorders metabolic disorders ocular disorders and oncological disorders.